...
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Impact of Adjuvant Therapy on Survival in Curatively Resected Gallbladder Carcinoma
【24h】

Impact of Adjuvant Therapy on Survival in Curatively Resected Gallbladder Carcinoma

机译:辅助治疗对胆囊癌根治性切除术后生存的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Gallbladder carcinoma (GBC) has the propensity to fail at loco-regional (LR) and distant sites despite aggressive radical surgery. Adjuvant therapy in the form of radiotherapy (RT), systemic chemotherapy (CT) and chemoradiation (CRT) is the usual practice. Due to rarity of this disease, there is limited evidence to suggest the type of adjuvant treatment which should be offered to the patients. Aim: The study was conducted to evaluate the impact of adjuvant treatment on curatively resected GBC patients. S ettings and Design: Histological proven patients of GBC registered between June, 2008 and July, 2014 were identified from our hospital database and retrospective analysis was done. Materials and Methods: Patients of GBC who had curative resection followed by adjuvant treatment as RT alone, CT alone or CRT were included in the study. S tatistical Analysis: Adverse prognostic factors and the effect of adjuvant treatment on overall survival (OS) and disease free survival (DFS) were evaluated using Cox Regression Method and Kaplan Meier plot. Results: We identified 33 patients of which 23 were Stage I or II disease (Early disease) and the remaining 10 were Stage III or IV disease (Advanced disease). All except one patient had adenocarcinoma. A total of 5 patients were treated with RT alone while 16 patients received CT alone. The remaining 12 patients were treated with CRT. Median follow-up period was 8.5 months. At analysis 4 were alive while the remaining 29 were Dead due to disease. With regard to ?Early disease? patients who had RT alone, CT alone and CRT, the median OS was 22.3, 10.3 and 15.2 months respectively (p = .440). Cohort of patients with ?Advanced disease? who were treated with CT alone and CRT the median OS was 7.5 and 7.0 months respectively (p = .643). On multivariate analysis none of the prognostic factors had an adverse impact on survival. Conclusion: The impact of adjuvant treatment in the form of RT, CT or CRT after curative resection in GBC patients was seen in terms of improved survival but was not statistically significant.
机译:背景:尽管进行了激进的根治性手术,胆囊癌(GBC)仍倾向于在局部区域(LR)和远处失败。放射疗法(RT),全身化学疗法(CT)和化学放射疗法(CRT)形式的辅助治疗是通常的做法。由于这种疾病的稀有性,只有很少的证据表明应该为患者提供辅助治疗的类型。目的:进行这项研究以评估辅助治疗对根治性切除的GBC患者的影响。设置与设计:从我们的医院数据库中识别出2008年6月至2014年7月登记的经GBC组织学证实的患者,并进行了回顾性分析。材料和方法:本研究包括GBC的患者,这些患者行根治性切除,然后接受单纯RT,CT或CRT辅助治疗。统计分析:使用Cox回归方法和Kaplan Meier图评估不良预后因素和辅助治疗对总生存期(OS)和无病生存期(DFS)的影响。结果:我们确定了33例患者,其中23例为I或II期疾病(早期疾病),其余10例为III或IV期疾病(晚期疾病)。除一名患者外,所有患者均患有腺癌。共有5例患者接受了仅RT的治疗,而16例患者仅接受了CT。其余12例患者接受了CRT治疗。中位随访期为8.5个月。在分析中,有4个还活着,而其余29个由于疾病而死亡。关于“早期疾病”?仅接受RT,仅接受CT和CRT的患者中位OS分别为22.3、10.3和15.2个月(p = .440)。患有“晚期疾病”的患者队列接受单独CT和CRT治疗的患者的中位OS分别为7.5和7.0个月(p = .643)。在多变量分析中,没有一个预后因素对生存有不利影响。结论:根治性切除术后以RT,CT或CRT形式辅助治疗对GBC患者的生存率有所改善,但无统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号